Skip to content
Clinical Trials – home

Prednisolone Sodium Phosphate: A Comprehensive Guide for Patients

3 / 3
trials open to patients / all trials
7+
Countries

In short

This article examines clinical trials investigating the use of Prednisolone Sodium Phosphate, a corticosteroid medication, in treating different medical conditions. The trials cover a range of applications, including asthma exacerbations in children, multiple sclerosis, pneumonia, and uveitis. These studies aim to evaluate the efficacy, safety, and optimal dosing of Prednisolone Sodium Phosphate compared to other treatments or placebo.

What is Prednisolone Sodium Phosphate?

Prednisolone Sodium Phosphate is a type of medication known as a corticosteroid. Corticosteroids are synthetic drugs that mimic the effects of hormones naturally produced by your adrenal glands. They are powerful anti-inflammatory agents, which means they help reduce swelling and inflammation in the body.

This medication is also known by other names, including:

  • Prednisolone
  • Prednesol

These alternative names may be used interchangeably by healthcare providers or on medication labels.

Medical Uses

Prednisolone Sodium Phosphate is used to treat a variety of conditions characterized by inflammation or overactivity of the immune system. Based on the clinical trials reviewed, it's commonly used for:

  1. Asthma: It's used to treat acute exacerbations (sudden worsening) of asthma in both adults and children. In some cases, it may be prescribed as a daily medication for severe asthma.
  2. Multiple Sclerosis (MS): Prednisolone is used to treat acute exacerbations of relapsing-remitting multiple sclerosis. MS is a condition where the immune system mistakenly attacks the protective covering of nerves.
  3. Pneumonia: Some studies are investigating its use in severe community-acquired pneumonia, which is a serious lung infection.
  4. B-cell Lymphomas: This is a type of cancer affecting white blood cells. Prednisolone is sometimes used as part of the treatment regimen.

How It's Administered

Prednisolone Sodium Phosphate can be administered in several ways, depending on the condition being treated and the patient's needs:

  • Oral tablets or liquid: Often prescribed for daily use in conditions like severe asthma.
  • Intravenous (IV) infusion: Used in hospital settings for acute conditions or when higher doses are needed.
  • Liposomal formulation: This is a newer form of the medication being studied, where the drug is encased in tiny fat bubbles. This may allow for more targeted delivery and potentially fewer side effects.

The dosage and duration of treatment can vary widely depending on the condition being treated and the individual patient's response.

Effectiveness

Prednisolone Sodium Phosphate has been shown to be effective in several conditions:

  • Asthma: It can significantly reduce inflammation in the airways, helping to relieve symptoms like wheezing and shortness of breath.
  • Multiple Sclerosis: It can help shorten the duration of MS relapses and may reduce the severity of symptoms.
  • Pneumonia: Some studies suggest it may help reduce mortality (death rates) in severe cases of pneumonia, though more research is needed.

However, it's important to note that the effectiveness can vary from person to person, and your doctor will monitor your response to the medication closely.

Potential Side Effects

Like all medications, Prednisolone Sodium Phosphate can cause side effects. Some potential side effects include:

  • Increased blood sugar levels (which can be a concern for people with diabetes)
  • Changes in mood or behavior
  • Increased appetite and weight gain
  • Fluid retention
  • Increased risk of infections

Long-term use of high doses may lead to more serious side effects, such as osteoporosis (weakening of bones), cataracts, or adrenal suppression (where your body stops producing its own cortisol).

It's crucial to discuss potential side effects with your healthcare provider and report any unusual symptoms you experience while taking this medication.

Ongoing Research

Researchers are continually studying Prednisolone Sodium Phosphate to understand its effects better and explore new potential uses:

  • Vascular Access for Dialysis: A study is investigating whether liposomal prednisolone can help improve the maturation of fistulas (surgically created blood vessel connections) used for hemodialysis in patients with kidney failure.
  • Comparison with Other Steroids: Some studies are comparing prednisolone to other corticosteroids like dexamethasone to determine which might be more effective or have fewer side effects in certain conditions.
  • New Formulations: Researchers are exploring new ways to deliver prednisolone, such as the liposomal formulation mentioned earlier, which might offer benefits over traditional forms of the medication.

These ongoing studies may lead to new uses for prednisolone or improvements in how it's administered in the future.

Questions people often ask

Conditions where Prednisolone Sodium Phosphate is being studied

Each condition opens its own overview and trial list

Trials with Prednisolone Sodium Phosphate

Recruiting trials first

See all 3 →
Quick filters
  • Participants:Children
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).